The chronic wound: impaired healing and solutions in the context of wound bed preparation.
暂无分享,去创建一个
[1] V. Falanga,et al. The longevity of a bilayered skin substitute after application to venous ulcers. , 2002, Archives of dermatology.
[2] P. Quesenberry,et al. The new stem cell biology. , 2002, Transactions of the American Clinical and Climatological Association.
[3] M. Longaker,et al. Studies in Fetal Wound Healing V. A Prolonged Presence of Hyaluronic Acid Characterizes Fetal Wound Fluid , 1991, Annals of surgery.
[4] D. Margolis,et al. A Literature Assessment of the Use of Miscellaneous Topical Agents, Growth Factors, and Skin Equivalents for the Treatment of Pressure Ulcers , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[5] K. Brismar,et al. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. , 1999, Diabetes care.
[6] R. Cooper,et al. Micro-organisms and wounds. , 1996, Journal of wound care.
[7] A. Hansson,et al. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of L‐lactate , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[8] Keith Harding,et al. Science, medicine and the future: healing chronic wounds. , 2002, BMJ.
[9] F. Grinnell,et al. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. , 1992, The Journal of investigative dermatology.
[10] William C. Parks,et al. The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix , 1997, The Journal of cell biology.
[11] C. Fife,et al. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1144 patients , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[12] L. Phillips,et al. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers , 1992, The Lancet.
[13] F. Gottrup. Prevention of surgical-wound infections. , 2000, The New England journal of medicine.
[14] T. Phillips,et al. Biologic skin substitutes. , 1993, The Journal of dermatologic surgery and oncology.
[15] I. K. Cohen,et al. Physiology of the chronic wound. , 1998, Clinics in plastic surgery.
[16] T. K. Hunt,et al. Wound healing and wound infection. What surgeons and anesthesiologists can do. , 1997, The Surgical clinics of North America.
[17] L. Bolton,et al. Microbiology and Healing of the Occluded Skin‐Graft Donor Site , 1993, Plastic and reconstructive surgery.
[18] M. Robson,et al. Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .
[19] M. Auletta,et al. Cultured skin as a 'smart material' for healing wounds: experience in venous ulcers. , 1996, Biomaterials.
[20] M. Longaker,et al. Adult Skin Wounds in the Fetal Environment Heal with Scar Formation , 1994, Annals of surgery.
[21] F. Grinnell,et al. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. , 1993, The Journal of investigative dermatology.
[22] L D Solem,et al. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. , 1997, The Journal of burn care & rehabilitation.
[23] Paul Martin,et al. Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.
[24] F. Logerfo,et al. Lack of association of diabetes with increased postoperative mortality and cardiac morbidity: results of 6565 major vascular operations. , 2002, Archives of surgery.
[25] W. Eaglstein,et al. The "trap" hypothesis of venous ulceration , 1993, The Lancet.
[26] G. Winter,et al. Formation of the Scab and the Rate of Epithelization of Superficial Wounds in the Skin of the Young Domestic Pig , 1962, Nature.
[27] Jerry S. Vandeberg,et al. Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. , 2000, Annals of surgery.
[28] J. Mansbridge,et al. Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: metabolic activity and therapeutic range. , 1998, Tissue engineering.
[29] L. Broemeling,et al. The Safety and Effect of Topically Applied Recombinant Basic Fibroblast Growth Factor on the Healing of Chronic Pressure Sores , 1992, Annals of surgery.
[30] A. Falabella,et al. Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. , 1997, Journal of dermatological science.
[31] M. Robson,et al. Bacterial quantification of open wounds. , 1969, Military medicine.
[32] B H Perry,et al. Efficacy and safety of becaplermin (recombinant human platelet‐derived growth factor‐BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[33] B. Gilchrest,et al. Workshop on the pathogenesis of chronic wounds. , 1994, The Journal of investigative dermatology.
[34] M. Robson,et al. Wound healing alterations caused by infection. , 1990, Clinics in plastic surgery.
[35] G. Schultz,et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[36] T. K. Hunt,et al. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. , 2000, Archives of surgery.
[37] J. Lawrence,et al. Wound infection under occlusive dressings. , 1991, The Journal of hospital infection.
[38] I. Leigh,et al. Clinical practice and biological effects of keratinocyte grafting. , 1991, Annals of the Academy of Medicine, Singapore.
[39] D. Steed,et al. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. , 1996, Journal of the American College of Surgeons.
[40] F. Logerfo,et al. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. , 1984, The New England journal of medicine.
[41] V. Falanga. Chronic wounds: pathophysiologic and experimental considerations. , 1993, The Journal of investigative dermatology.
[42] J. Hansbrough,et al. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. , 1997, The Journal of burn care & rehabilitation.
[43] S. Werner,et al. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. , 1998, Experimental cell research.
[44] T. Helfman,et al. Occlusive dressings and wound healing. , 1994, Clinics in dermatology.
[45] R. Allman,et al. Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. , 1994, The American journal of pathology.
[46] B. Gilchrest,et al. Clinical applications of cultured epithelium. , 1992, Epithelial cell biology.
[47] I. K. Cohen,et al. Scarless wound healing in the mammalian fetus. , 1992, Surgery, gynecology & obstetrics.
[48] G. O’Toole,et al. The role of bacterial biofilms in ocular infections. , 2002, DNA and cell biology.
[49] M. Longaker,et al. Scarless healing. The fetal wound. , 1998, Clinics in plastic surgery.
[50] J. Hansbrough,et al. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. , 1992, The Journal of burn care & rehabilitation.
[51] D. Faller,et al. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. , 1991, The Journal of clinical investigation.
[52] S. Myers,et al. Culturing skin in vitro for wound therapy. , 1995, Trends in biotechnology.
[53] S. Kourembanas. Hypoxia and carbon monoxide in the vasculature. , 2002, Antioxidants & redox signaling.
[54] J. R. Mekkes,et al. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation , 1999, Archives of Dermatological Research.
[55] B. Rubin,et al. Safety, feasibility, and early efficacy of subfascial endoscopic perforator surgery: a preliminary report from the North American registry. , 1997, Journal of vascular surgery.
[56] M. Sporn,et al. Hypoxia upregulates the synthesis of tgf-β1 by human dermal fibroblasts , 1991 .
[57] J. McMahon,et al. Predicting healing of lower limb ulcers. , 1995, The Australian and New Zealand journal of surgery.
[58] J. Isner,et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. , 1998, Journal of vascular surgery.
[59] V. Falanga,et al. Wounding of bioengineered skin: cellular and molecular aspects after injury. , 2002, The Journal of investigative dermatology.
[60] M. Siroky. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. , 2002, The American journal of medicine.
[61] V. Falanga,et al. Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF‐β1 , 2002, Journal of cellular physiology.
[62] I. K. Cohen,et al. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. , 1996, The Journal of investigative dermatology.
[63] A. Singer,et al. Cutaneous wound healing. , 1999, The New England journal of medicine.
[64] U. Tantry,et al. Stimulation of fibroblast proliferation and matrix contraction by wound fluid. , 1997, International Journal of Biochemistry and Cell Biology.
[65] L C Parish,et al. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor‐2) to accelerate wound healing in venous ulcers , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[66] E. Middelkoop,et al. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. , 1998, The Journal of investigative dermatology.
[67] F. Yao,et al. Gene therapy in wound repair and regeneration , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[68] A. Vaheri,et al. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. , 1996, The Journal of investigative dermatology.
[69] H. Maibach,et al. Effect of Air Exposure and Occlusion on Experimental Human Skin Wounds , 1963, Nature.
[70] R. Tompkins,et al. Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. , 1998, Human gene therapy.
[71] K. Poskitt,et al. Surgical correction of isolated superficial venous reflux reduces long-term recurrence rate in chronic venous leg ulcers. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[72] W. Eaglstein,et al. Inhibition of cell proliferation by chronic wound fluid , 1993, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[73] L. Ovington. Wound care products: how to choose. , 2001, Home healthcare nurse.
[74] S. A. Bruce,et al. Longitudinal study of in vivo wound repair and in vitro cellular senescence of dermal fibroblasts , 1991, Experimental Gerontology.
[75] V. Falanga. Classifications for wound bed preparation and stimulation of chronic wounds , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[76] E. Dabelsteen,et al. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. , 1999, The Journal of investigative dermatology.
[77] K. Burnand,et al. Effect of venous ulcer exudates on angiogenesis in vitro , 2002, The British journal of surgery.
[78] V. Falanga,et al. Extravasation of macromolecules and possible trapping of transforming growth factor‐β in venous ulceration , 1995, The British journal of dermatology.
[79] R. Kirsner,et al. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. , 1991, Journal of the American Academy of Dermatology.
[80] M. Robson. Growth factors as wound healing agents , 1992, Current Biology.
[81] D. Faller,et al. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. , 1990, The Journal of clinical investigation.
[82] J. Apelqvist. Wound healing in diabetes. Outcome and costs. , 1998, Clinics in podiatric medicine and surgery.
[83] D. Supp,et al. Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[84] E Bell,et al. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. , 1981, Science.
[85] A. Wysocki. Evaluating and managing open skin wounds: colonization versus infection. , 2002, AACN clinical issues.
[86] E. Middelkoop,et al. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. , 2002, European journal of cell biology.
[87] G. G. Gallico. Biologie Skin Substitutes , 1990 .
[88] D. Steed. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. , 1995, Journal of vascular surgery.
[89] T. Osler,et al. Senescence and the healing rates of venous ulcers. , 2001, Journal of vascular surgery.
[90] David G Armstrong,et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. , 2001, Diabetes care.
[91] J. Ricotta,et al. Use of Dermagraft, a Cultured Human Dermis, to Treat Diabetic Foot Ulcers , 1996, Diabetes Care.
[92] W. Eaglstein,et al. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. , 1992, The Journal of dermatologic surgery and oncology.
[93] S. Boyce,et al. Design principles for composition and performance of cultured skin substitutes. , 2001, Burns : journal of the International Society for Burn Injuries.
[94] M. Roberts,et al. Defining a model to predict the distribution of topically applied growth factors and other solutes in excisional full-thickness wounds. , 1999, The Journal of investigative dermatology.
[95] V. Falanga,et al. Treatment of chronic wounds with bone marrow-derived cells. , 2003, Archives of dermatology.